SCHEMBL30697818

SCHEMBL30697818

N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 5/20 0.40
▸ F2 P00734 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ REN P00797 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ LTA4H P09960 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ PEPD P12955 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ PTGS1 P23219 1/20 0.40
▸ HTR2A P28223 1/20 0.40
▸ PTGS2 P35354 1/20 0.40
▸ HRH1 P35367 1/20 0.40
▸ THPO P40225 1/20 0.40
▸ PMP22 Q01453 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ ACE2 Q9BYF1 1/20 0.40
▸ CHRM3 P20309 3/20 0.38
▸ XPNPEP2 O43895 1/20 0.38
▸ CHRM2 P08172 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29816616 1.00 ACE (0.40) ACEF2KDM4ERENLMNA
SCHEMBL29411119 0.91 ACE (0.47) ACEF2KDM4ERENLMNA
SCHEMBL30785840 0.89 CHRM2 (0.44) CHRM3CHRM2
SCHEMBL29816354 0.89 CHRM2 (0.44) CHRM3CHRM2
SCHEMBL30697814 0.89 CHRM2 (0.44) CHRM3CHRM2
SCHEMBL30785841 0.87 VHL (0.38) CHRM3CHRM2
SCHEMBL29816645 0.87 VHL (0.38) CHRM3CHRM2
SCHEMBL29936940 0.86 PREP (0.40) ACEF2KDM4ERENLMNA
SCHEMBL30697795 0.85 DPP7 (0.48) ACEF2DPP4
SCHEMBL29816184 0.85 DPP7 (0.48) ACEF2DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543480-A2 COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND USES THEREOF Sustain Holdings, LLC (US) 2025-04-30 — — EP disclosed
CN-119698289-A Pharmaceutical composition based on collagen peptide and application thereof 莎思坦控股有限责任公司 2025-03-25 — — CN disclosed
CN-118750586-A Collagen-based pharmaceutical compositions and devices and methods of manufacture and use thereof 莎思坦控股有限责任公司 2024-10-11 — — CN disclosed
CN-118750585-A Collagen-based pharmaceutical compositions and devices and methods of manufacture and use thereof 莎思坦控股有限责任公司 2024-10-11 — — CN disclosed
CN-118717953-A Collagen-based pharmaceutical compositions and devices and methods of manufacture and use thereof 莎思坦控股有限责任公司 2024-10-01 — — CN disclosed
US-20240016900-A1 COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND USES THEREOF SUSTAIN HOLDINGS, LLC 2024-01-18 — — US disclosed
WO-2024006771-A2 COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND USES THEREOF SUSTAIN HOLDINGS, LLC (US) 2024-01-04 — — WO disclosed
Send feedback